| Width | 200px |
|---|---|
| Width 2 | 225px |
| Routes of administration | Oral |
| Class | Non-selective serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen |
| Atc prefix | None |
| Cas number | 2595431-59-5 |
| Pubchem | 138454310 |
| Chemspiderid | 129433801 |
| Unii | Y3J8M5UX6G |
| Synonyms | 4-OH-EPT; 4-Hydroxy-N-ethyl-N-propyltryptamine; Eprocin |
| Iupac name | 3-{2-[ethyl(propyl)amino]ethyl}-1H-indol-4-ol |
| C | 15 |
| H | 22 |
| N | 2 |
| O | 1 |
| Smiles | CCCN(CC)CCC1=CNC2=CC=CC(O)=C12 |
| Stdinchi | 1S/C15H22N2O/c1-3-9-17(4-2)10-8-12-11-16-13-6-5-7-14(18)15(12)13/h5-7,11,16,18H,3-4,8-10H2,1-2H3 |
| Stdinchikey | JQELEPKHBXEAHR-UHFFFAOYSA-N |
4-HO-EPT, also known as 4-hydroxy-N-ethyl-N-propyltryptamine or as eprocin, is a psychedelic drug of the tryptamine family, which is structurally related to psilocin (4-HO-DMT).[1] It was encountered as a novel designer drug in Japan by 2021.[1]
Use and effects
4-HO-EPT was not included nor mentioned in Alexander Shulgin's book TiHKAL (Tryptamines I Have Known and Loved).[2] Subsequently, however, an assumed prodrug of 4-HO-EPT, 4-AcO-EPT, has emerged as a novel designer drug, and has been said based on online anecdotal reports to have a dose of 20 to 30 mg orally.[3][4]
Interactions
Pharmacology
Pharmacodynamics
| Target | Affinity (Ki, nM) |
|---|---|
| 5-HT1A | 163 |
| 5-HT1B | 1,097 |
| 5-HT1D | 644 |
| 5-HT1E | 591 |
| 5-HT2A | 546 (Ki) 3.2 (EC50) 100% (Emax) |
| 5-HT2B | 62 (Ki) 4.3 (EC50) 89% (Emax) |
| 5-HT2C | 1,272 (Ki) 129 (EC50) 89% (Emax) |
| 5-HT5A | 1,576 |
| 5-HT6 | 284 |
| 5-HT7 | 438 |
| α2A | 2,073 |
| α2B, α2C | >10,000 |
| D2 | 3,010 |
| D3 | 985 |
| D4, D5 | >10,000 |
| H1 | 406 |
| H2 | >10,000 |
| M4 | >10,000 |
| σ1 | 1,400 |
| σ2 | 1,773 |
| KOR | >10,000 |
| NR2B | 5,947 |
| SERT | 1,257 |
| DAT | >10,000 |
| Notes: The smaller the value, the more avidly the drug interacts with the site. Sources: [5][6] | |
4-HO-EPT is a potent full agonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors.[5][6] It has one to two orders of magnitude greater potency as a serotonin 5-HT2A and 5-HT2B receptor agonist than as a serotonin 5-HT2C receptor agonist.[5] The drug also shows affinity for other serotonin receptors, such as the serotonin 5-HT1A and 5-HT6 receptors.[6] 4-HO-EPT produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.[5]
Pharmacokinetics
The metabolism of 4-HO-EPT has been studied.[7]
Chemistry
Analogues
Analogues of 4-HO-EPT include ethylpropyltryptamine (EPT), 5-MeO-EPT, 5-fluoro-EPT, 4-HO-MPT, 4-HO-PiPT, 4-HO-DET, and 4-HO-DPT, among others.
Society and culture
Legal status
Canada
4-HO-EPT is not a controlled substance in Canada as of 2025.[8]
United Kingdom
4-HO-EPT is illegal in the United Kingdom as a result of the Psychoactive Substances Act of 2016.[9]
United States
4-HO-EPT may be considered an analogue of psilocin, which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption would be illegal under the Federal Analogue Act.[citation needed]
See also
References
- ^ Tanaka R, Kawamura M, Hakamatsuka T, Kikura-Hanajiri R (2021). "Identification of six tryptamine derivatives as designer drugs in illegal products". Forensic Toxicology. 39 (1): 248–258. doi:10.1007/s11419-020-00556-5. ISSN 1860-8965. Retrieved 9 October 2025.
- ^
- ^ "4-OH-EPT AC (4-AcO-EPT)" (in Russian). АИПСИН. Retrieved 2 January 2026.
- ^ "4-HO-EPT AC (4-AcO-EPT)" (in Russian). АИПСИН. Retrieved 2 January 2026.
- ^ Klein AK, Chatha M, Laskowski LJ, Anderson EI, Brandt SD, Chapman SJ, McCorvy JD, Halberstadt AL (April 2021). "Investigation of the Structure-Activity Relationships of Psilocybin Analogues". ACS Pharmacology & Translational Science. 4 (2): 533–542. doi:10.1021/acsptsci.0c00176. PMC 8033608. PMID 33860183
- ^ Glatfelter GC, Naeem M, Pham DN, Golen JA, Chadeayne AR, Manke DR, Baumann MH (April 2023). "Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice". ACS Pharmacology & Translational Science. 6 (4): 567–577. doi:10.1021/acsptsci.2c00222. PMC 10111620. PMID 37082754
- ^ Bergh MS, Bogen IL, Grafinger KE, Huestis MA, Øiestad ÅM (December 2024). "Metabolite markers for three synthetic tryptamines N-ethyl-N-propyltryptamine, 4-hydroxy-N-ethyl-N-propyltryptamine, and 5-methoxy-N-ethyl-N-propyltryptamine". Drug Testing and Analysis. 16 (12): 1544–1557. doi:10.1002/dta.3668. PMC 11635065. PMID 38459837
- ^ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
- ^ "Misuse of Drugs Act 1971 (Legislation.gov.uk)"